Showing results (451-460 of 650) with videos related to
Sort By:
Pageof 65
Nature Cancer|October 23, 2023
Systematic evaluation of AML-associated antigens identifies anti-U5 SNRNP200 therapeutic antibodies for the treatment of acute myeloid leukemiaKatherine Knorr, Jahan Rahman, Caroline Erickson, et al.Nature Cancer|July 24, 2023
Single-cell analyses implicate ascites in remodeling the ecosystems of primary and metastatic tumors in ovarian cancerXiaocui Zheng, Xinjing Wang, Xi Cheng, et al.Nature Cancer|July 25, 2023
Leveraging translational insights toward precision medicine approaches for brain metastasesAlbert E Kim, Edwin Nieblas-Bedolla, Magali A de Sauvage, et al.Nature Cancer|July 17, 2023
The Akt/mTOR and MNK/eIF4E pathways rewire the prostate cancer translatome to secrete HGF, SPP1 and BGN and recruit suppressive myeloid cellsDaniela Brina, Adele Ponzoni, Martina Troiani, et al.Nature Cancer|August 31, 2023
Clinical and translational advances in ovarian cancer therapyPanagiotis A Konstantinopoulos, Ursula A MatulonisNature Cancer|September 4, 2023
Performance and effectiveness of hepatocellular carcinoma screening in individuals with HBsAg seropositivity in China: a multicenter prospective studyHongmei Zeng, Maomao Cao, Changfa Xia, et al.Nature Cancer|June 5, 2023
Non-lethal outcomes of engaging regulated cell death pathways in cancerHalime Kalkavan, Sebastian Rühl, Jeremy J P Shaw, et al.Nature Cancer|June 5, 2023
An allosteric pan-TEAD inhibitor blocks oncogenic YAP/TAZ signaling and overcomes KRAS G12C inhibitor resistanceThijs J Hagenbeek, Jason R Zbieg, Marc Hafner, et al.Nature Cancer|September 25, 2023
Endothelial Notch1 signaling in white adipose tissue promotes cancer cachexiaJacqueline Taylor, Leonie Uhl, Iris Moll, et al.Nature Cancer|September 11, 2023
A designer peptide against the EAG2-Kvβ2 potassium channel targets the interaction of cancer cells and neurons to treat glioblastomaWeifan Dong, Adam Fekete, Xiaodi Chen, et al.Pageof 65